Stock Events

Stock Events

Whitehawk Therapeutics 

$4.73
42
-$0.10-2.07% Friday 20:00
+$0.00+0%Friday 23:30After hours

Statistics

Day High
4.74
Day Low
4.72
52W High
5.5
52W Low
1.68
Volume
14,221
Avg. Volume
-
Mkt Cap
269.65M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

11NovExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-0.76
0.1
0.97
1.83
Expected EPS
-0.221429
Actual EPS
N/A

Financials

-288.26%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
7.15MRevenue
-20.6MNet Income

Analyst Ratings

9.00Average Price Target
The highest estimate is 10.00.
From 2 ratings within the last 6 months. This is not an investment recommendation.
Buy
50%
Hold
50%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow WHWK. It's not an investment recommendation.
Tesla
3
TSLA
AT&T
3
T
Altria Group
3
MO
Main Street Capital
3
MAIN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Array Technologies
ARRY
Mkt Cap777.74M
Array BioPharma, acquired by Pfizer, focuses on the discovery, development, and commercialization of targeted small molecule drugs to treat cancer, directly competing with Aadi Bioscience.
AMGEN
AMGN
Mkt Cap224.63B
Amgen has a broad portfolio of treatments, including for cancer, and its focus on innovative therapies makes it a competitor in the oncology space where Aadi Bioscience operates.
Exelixis
EXEL
Mkt Cap12.7B
Exelixis is focused on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers, competing with Aadi Bioscience's niche.
Incyte
INCY
Mkt Cap24.36B
Incyte Corporation has a strong focus on oncology, including targeted cancer therapies, making it a direct competitor to Aadi Bioscience.
Novartis
NVS
Mkt Cap286.78B
Novartis is a large pharmaceutical company with a significant investment in developing treatments for various cancers, including targeted therapies that compete with Aadi Bioscience.
Pfizer
PFE
Mkt Cap152.69B
Pfizer has a diverse oncology portfolio, including targeted therapies and precision medicine, making it a competitor in the same field as Aadi Bioscience.

About

Whitehawk Therapeutics Inc is an oncology therapeutics company applying technologies to tumor biology to develop cancer treatments. Its portfolio includes three antibody-drug conjugate (ADC) candidates designed to address limitations of earlier therapies for patients with difficult-to-treat cancers. The company generates revenue from the sale of its products.
Show more...
CEO
David J. Lennon
Employees
23
Country
United States
ISIN
US00032Q1040
WKN
000A3CSR9

Listings

XNAS
US
WHWK
F
DE
3350.F
STU
DE
3350.STU
MU
DE
3350.MU

0 Comments

Share your thoughts

FAQ

What is Whitehawk Therapeutics stock price today?▼
The current price of WHWK is $4.73 USD — it has decreased by -2.07% in the past 24 hours. Watch Whitehawk Therapeutics stock price performance more closely on the chart.
What is Whitehawk Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Whitehawk Therapeutics stocks are traded under the ticker WHWK.
Is Whitehawk Therapeutics stock price growing?▼
WHWK stock has risen by +6.05% compared to the previous week, the month change is a +18.55% rise, over the last year Whitehawk Therapeutics has showed a +171.84% increase.
What is Whitehawk Therapeutics market cap?▼
Today Whitehawk Therapeutics has the market capitalization of 269.65M
When is the next Whitehawk Therapeutics earnings date?▼
Whitehawk Therapeutics is going to release the next earnings report on November 11, 2026.
What were Whitehawk Therapeutics earnings last quarter?▼
WHWK earnings for the last quarter are -0.2 USD per share, whereas the estimation was -0.3 USD resulting in a +32.37% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Whitehawk Therapeutics revenue for the last year?▼
Whitehawk Therapeutics revenue for the last year amounts to 7.15M USD.
What is Whitehawk Therapeutics net income for the last year?▼
WHWK net income for the last year is -20.6M USD.
How many employees does Whitehawk Therapeutics have?▼
As of August 22, 2026, the company has 23 employees.
In which sector is Whitehawk Therapeutics located?▼
Whitehawk Therapeutics operates in the Health & Wellness sector.
When did Whitehawk Therapeutics complete a stock split?▼
The last stock split for Whitehawk Therapeutics was on August 27, 2021 with a ratio of 1:15.
Where is Whitehawk Therapeutics headquartered?▼
Whitehawk Therapeutics is headquartered in MORRISTOWN, United States.